| Literature DB >> 33335224 |
Agnieszka Antończyk1, Monika E Danielewska2, Dominika Kubiak-Nowak3, Wojciech Borawski3, Zdzisław Kiełbowicz3.
Abstract
The aim was to assess the relationships between cardiovascular activity, corneal pulse characteristics, and corneal biomechanics in rabbits. Seventeen rabbits were randomly assigned to one of two anesthetic regimens to induce differences in arterial blood pressure and heart rate. Experimental protocol included measuring blood flow parameters in the ophthalmic artery by color Doppler imaging, corneal biomechanical parameters using a non-contact tonometer Corvis ST, and the corneal pulse (CP) signal using a non-contact ultrasonic technique. Statistically significantly lower mean values of normalized amplitudes of higher CP harmonics and changes in eight of the twelve corneal biomechanical parameters were observed in the rabbit group with lower arterial blood pressure and higher heart rate, intraocular pressure, and resistive index. The results of partial correlations showed that the CP signal energy and amplitude of its first harmonic correlate with the resistive index, diastolic and mean arterial pressures, whereas no statistically significant correlation was found between any of the CP parameters and intraocular pressure. Our pilot study indicates, for the first time, that non-contact and continuous measuring of corneal pulse allows indirectly assessing changes in cardiovascular activity when the confounding effect of intraocular pressure is eliminated.Entities:
Mesh:
Year: 2020 PMID: 33335224 PMCID: PMC7747746 DOI: 10.1038/s41598-020-79219-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Group averages of heart rate (HR), systolic (SBP), diastolic (DBP) and mean arterial blood pressure (MBP) at different time points in Group I and II. Error bars denote one standard error.
Descriptive statistics for all considered parameters and the results of Levene’s test and unpaired t-test.
| Parameter | Mean ± SD (ranges) | Levene’s test | ||||
|---|---|---|---|---|---|---|
| Group I | Group II | |||||
| HR (beats/min) | 224 ± 20 | 150 ± 12 | 2.910 | 0.109 | 9.615 | |
| (200–250) | (126–171) | |||||
| SBP (mmHg) | 67 ± 6 | 88 ± 10 | 2.353 | 0.146 | 5.223 |
|
| (59–77) | (71–99) | |||||
| DBP (mmHg) | 46 ± 6 | 70 ± 10 | 1.052 | 0.321 | 6.434 | |
| (39–53) | (55–88) | |||||
| MBP (mmHg) | 54 ± 5 | 78 ± 10 | 2.252 | 0.154 | 6.758 | |
| (48–60) | (62–93) | |||||
| PSV (cm/s) | 25.0 ± 7.5 | 22.9 ± 9.8 | 0.315 | 0.583 | 0.500 | 0.624 |
| (14.6–33.8) | (11.9–38.8) | |||||
| EDV (cm/s) | 10.1 ± 3.9 | 12.2 ± 7.0 | 2.306 | 0.150 | 0.739 | 0.472 |
| (4.9–17.0) | (4.6–26.4) | |||||
| RI (–) | 0.60 ± 0.08 | 0.48 ± 0.10 | 0.230 | 0.638 | 2.593 | |
| (0.50–0.73) | (0.32–0.64) | |||||
| IOP (mmHg) | 14.7 ± 2.4 | 9.7 ± 2.1 | 0.001 | 0.974 | 4.654 |
|
| (10.3–17.7) | (6.5–12.0) | |||||
| CCT ( | 371 ± 34 | 361 ± 25 | 0.404 | 0.534 | 0.726 | 0.479 |
| (333–438) | (322–401) | |||||
| A1T (ms) | 7.0 ± 0.4 | 6.7 ± 0.2 | 2.570 | 0.130 | 2.692 |
|
| (6.5–7.5) | (6.4–6.9) | |||||
| A2T (ms) | 22.5 ± 3.4 | 21.8 ± 0.3 | 4.866 | 0.043 | 0.626 | 0.551 |
| (21.0–30.8) | (21.3–22.3) | |||||
| A1L (mm) | 2.0 ± 0.3 | 1.8 ± 0.08 | 11.852 | 0.004 | 2.547 |
|
| (1.8–2.4) | (1.7–2.0) | |||||
| A2L (mm) | 1.6 ± 0.4 | 1.2 ± 0.4 | 0.315 | 0.583 | 2.139 | |
| (1.1–2.1) | (0.7–1.9) | |||||
| A1V (m/s) | 0.14 ± 0.02 | 0.17 ± 0.03 | 1.283 | 0.275 | 2.483 | |
| (0.12–0.17) | (0.14–0.23) | |||||
| A2V (m/s) | 0.990 | 5.274 | ||||
| ( | ( | |||||
| HCT (ms) | 16.9 ± 0.4 | 16.9 ± 0.6 | 1.789 | 0.201 | 0.186 | 0.855 |
| (16.5–17.6) | (15.9–17.6) | |||||
| DA (mm) | 1.2 ± 0.1 | 1.4 ± 0.2 | 1.713 | 0.210 | 4.268 | |
| (1.0–1.3) | (1.2–1.6) | |||||
| PD (mm) | 4.2 ± 1.3 | 3.2 ± 0.8 | 5.323 | 0.036 | 1.913 | 0.082 |
| (2.2–5.2) | (2.5–4.4) | |||||
| R (mm) | 5.0 ± 0.4 | 4.5 ± 0.3 | 1.952 | 0.183 | 3.098 | |
| (4.4–5.7) | (4.1–5.0) | |||||
| RMS ( | 13.1 ± 4.6 | 14.0 ± 6.9 | 1.312 | 0.270 | 0.316 | 0.756 |
| (6.2–17.4) | (5.5–25.9) | |||||
| A1 ( | 7.2 ± 3.1 | 7.4 ± 4.3 | 0.978 | 0.338 | 0.085 | 0.933 |
| (2.4–10.2) | (2.6–14.1) | |||||
| A2n (–) | 0.36 ± 0.11 | 0.19 ± 0.06 | 3.771 | 0.071 | 4.522 | |
| (0.27–0.53) | (0.13–0.28) | |||||
| A3n (–) | 0.15 ± 0.06 | 0.06 ± 0.03 | 4.784 | 0.045 | 4.120 | |
| (0.07–0.24) | (0.03–0.12) | |||||
| A4n (–) | 0.11 ± 0.05 | 0.04 ± 0.02 | 5.037 | 0.040 | 4.030 | |
| (0.06–0.18) | (0.01–0.07) | |||||
Bolded values indicate in the t-test.
Figure 2Means ± standard errors of blood pressures for the two study groups. SBP—systolic blood pressure, MBP—mean blood pressure, DBP—diastolic blood pressure.
Figure 3Means ± standard errors of uncorrected intraocular pressure, IOP, (a) and arterial resistive index, RI, (b) for the two groups.
Figure 4Means ± standard errors of the normalized amplitudes of the second, third, and fourth harmonic (A2n, A3n, A4n) of the corneal pulse (CP) signal (a) and the maximum deformation amplitude (DA) (b) for the two study groups.
Results of partial correlation analysis (cor) between the CP signal parameters and those of blood and intraocular pressure, blood flow in the external ophthalmic artery, and corneal biomechanics, with Group used as a control variable.
| Parameters | cor | HR | SBP | DBP | MBP | PSV | EDV | RI | IOP | CCT | A1T | A2T | A1L | A2L | A1V | A2V | HCT | DA | PD | R |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RMS | .160 | .174 | .376 | .488 | ||||||||||||||||
| .691 | .262 | .628 | .170 | .271 | .092 | .400 | .368 | .518 | .555 | .520 | .088 | .151 | .055 | .397 | .287 | |||||
| A1 | -.095 | .128 | .210 | .370 | .449 | |||||||||||||||
| .727 | .296 | .519 | .146 | .220 | .170 | .312 | .462 | .559 | .635 | .435 | .110 | .158 | .081 | .524 | .366 | |||||
| A2n | .036 | .010 | .094 | .199 | .467 | .187 | .288 | .427 | .160 | |||||||||||
| .921 | .712 | .896 | .786 | .970 | .963 | .730 | .460 | .068 | .487 | .213 | .724 | .279 | .099 | .818 | .553 | .441 | ||||
| A3n | .294 | .108 | .017 | .299 | .198 | .054 | .402 | .076 | .347 | .081 | .068 | .341 | ||||||||
| .269 | .697 | .692 | .949 | .261 | .463 | .844 | .927 | .123 | .601 | .781 | .188 | .854 | .866 | .764 | .968 | .803 | .196 | .551 | ||
| A4n | -.101 | .104 | .020 | .252 | .268 | .130 | .082 | .178 | .115 | .251 | .057 | .030 | ||||||||
| .792 | .709 | .703 | .940 | .346 | .316 | .763 | .631 | .762 | .511 | .671 | .348 | .507 | .728 | .835 | .929 | .708 | .913 | .448 |
Statistically significant results are bolded.
Results of partial correlation analysis (cor) between the CP signal parameters and those of blood and intraocular pressure, blood flow in the external ophthalmic artery, and corneal biomechanics, with Group and IOP used as control variables.
| Parameters | cor | HR | SBP | DBP | MBP | PSV | EDV | RI | CCT | A1T | A2T | A1L | A2L | A1V | A2V | HCT | DA | PD | R |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RMS | .092 | .244 | -.137 | -.356 | .472 | .416 | -.302 | ||||||||||||
| .651 | .401 | .575 | .185 | .081 | .743 | .378 | .506 | .380 | .627 | .193 | .075 | .123 | .274 | .295 | |||||
| A1 | -.117 | .056 | .221 | -.120 | .479 | .328 | |||||||||||||
| .679 | .463 | .460 | .157 | .149 | .842 | .470 | .541 | .429 | .671 | .260 | .071 | .233 | .364 | .373 | |||||
| A2n | .049 | .024 | .179 | .483 | .019 | .132 | .223 | .401 | .113 | .206 | |||||||||
| .950 | .551 | .864 | .766 | .934 | .934 | .524 | .068 | .948 | .147 | .640 | .423 | .138 | .688 | .461 | .438 | ||||
| A3n | .293 | .106 | .019 | .298 | .199 | .048 | .401 | .076 | .347 | .107 | .071 | .343 | |||||||
| .289 | .716 | .706 | .948 | .281 | .477 | .866 | .138 | .320 | .787 | .206 | .872 | .665 | .704 | .985 | .802 | .211 | .568 | ||
| A4n | -.146 | .113 | .015 | .264 | .264 | .087 | .140 | .113 | .255 | .027 | -.008 | -.054 | .056 | ||||||
| .815 | .604 | .690 | .958 | .342 | .342 | .891 | .758 | .618 | .688 | .359 | .438 | .924 | .978 | .847 | .962 | .842 | .454 |
Statistically significant results are bolded.
Data comparison between published studies on relationship between arterial blood pressure (ABP) and intraocular pressure (IOP).
| References | Treatment | Species | Relationship between ABP and IOP | |
|---|---|---|---|---|
| [ | No | Human | 4764 | Positive |
| [ | No | Human | 4926 | Positive |
| [ | Norepinephrine (0.03 to 30 | Cat | 32 | Positive |
| Methacholine (0.01 to 3.0 | Cat | 40 | Positive | |
| Isoproterenol (0.03 to 1.0 | Cat | 40 | Positive | |
| [ | No | Rat | 39 | Negative in hypertensive rats; no in normotensive rats |
| Kallikrein (150 KU/kg) | Rat | 14 | Positive | |
| Bradykinin (3 | Rat | 26 | No | |
| Angiotensin I (3 | Rat | 14 | No | |
| Angiotensin II (3 | Rat | 27 | No | |
| Bloodletting (2 mL) | Rat | 14 | No | |
| [ | Propofol (0.98 mg/kg) | Human | 20 | Positive |
| [ | Fentanyl (0.01 mg/kg) | Dog | 10 | No |
| Medetomidine (0.01 mg/kg) | Dog | 10 | No | |
| Acepromazine (0.02 mg/kg) | Dog | 10 | No | |
| Butorphanol (0.2 mg/kg) | Dog | 10 | No | |
| [ | Thiopental sodium (5 to 6 mg/kg) | Human | 23 | Positive |
| Remifentanil (CRI) | ||||
| Desflurane (inhalant) | ||||
| Rocuronium (1 mg/kg) | ||||
| Propofol (1.5 to 2.5 mg/kg bolus) + CRI remifentanil (CRI) rocuronium (1 mg/kg) | Human | 23 | Positive |